Health

Abivax Drug Trial Update

Updated 2026-06-30 07:10 UTC 1 source Positive

Abivax's experimental bowel disease drug faced safety concerns but new data has boosted company shares. The drug trial results are a significant development for the pharmaceutical industry.

Coverage timeline — 1 article

STAT News

STAT+: Abivax seeks to ease safety concerns with new data, boosting shares

Safety concerns tied to Abivax's experimental bowel disease drug tanked company shares just weeks ago. But a new analysis sent them climbing.

2026-06-30 07:05 UTC